Despite the popularity of GLP-1 diet pills and investors wor...

Despite the popularity of GLP-1 diet pills and investors worried that food companies' earnings are being pressured, Coca Cola and Pepsi said there was no significant impact on the business. Morgan Stanley said drug users who cut their daily calories by 30% did not cause the two companies' sales to decline.